Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |